41 results
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, either alone or with other treatments.

Acthar (repository corticotropin)

(Repository Corticotropin)
Mallinckrodt ARD LLC
Usage: Acthar Gel is indicated for treating infantile spasms in young children, acute exacerbations of multiple sclerosis in adults, and as adjunctive therapy for various rheumatic and collagen diseases. It's also used in severe dermatologic conditions, allergic states, ophthalmic diseases, respiratory issues like sarcoidosis, and edematous states.
Amgen Inc
Usage: AMJEVITA is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and improve patient function. It can be used alone or with other medications.

Avsola (infliximab-axxq)

(infliximab-axxq)
Amgen Inc
Usage: AVSOLA is indicated for managing moderately to severely active Crohn's disease and ulcerative colitis in adults and pediatric patients, as well as for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults, particularly when prior therapies are inadequate.
UCB, Inc.
Usage: BIMZELX is indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, active non-radiographic axial spondyloarthritis with inflammation, active ankylosing spondylitis, and moderate to severe hidradenitis suppurativa in adults.

Cimzia (certolizumab pegol)

(certolizumab pegol)
UCB, Inc.
Usage: CIMZIA is indicated for reducing signs and symptoms in Crohn's disease, treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, active psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and moderate-to-severe plaque psoriasis in adults and patients aged 2 and older.
Novartis Pharmaceuticals Corporation
Usage: COSENTYX® is indicated for moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis in those 2 years and older, ankylosing spondylitis in adults, non-radiographic axial spondyloarthritis in adults, active enthesitis-related arthritis in patients 4 years and older, and moderate to severe hidradenitis suppurativa in adults.

Cyltezo (adalimumab-adbm)

(adalimumab-adbm)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. It can be used alone or with non-biologic DMARDs, depending on the condition.
Henry Schein, Inc.
Usage: This drug is indicated for various conditions such as endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, dermatologic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, and cerebral edema. It can be administered via injection or intra-articular methods.
Immunex Corporation
Usage: Enbrel is indicated for treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, chronic moderate to severe plaque psoriasis, and active juvenile psoriatic arthritis in patients aged 2 and older. It can be used with or without methotrexate.